Cytosorbents (CTSO) Other Non-Current Liabilities (2014 - 2017)

Cytosorbents has reported Other Non-Current Liabilities for 4 years, with the latest figure at $1.0 million in Q2 2017.

• For the quarter ending Q2 2017, Other Non-Current Liabilities fell 42.13% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2017 stood at $1.0 million (down 42.13% YoY), and the FY2016 full-year result was $1.8 million, up 10.72% from the prior year.
• Other Non-Current Liabilities for Q2 2017 stood at $1.0 million, down from $1.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $3.0 million in Q4 2014, with the low at $1.0 million in Q2 2017.
• Historically, Other Non-Current Liabilities has averaged $1.9 million across 4 years, with a median of $1.7 million in 2016.
• Annual changes were most pronounced in 2015 — Other Non-Current Liabilities tumbled 45.12% — and 2016, when it rose 10.72%.
• Cytosorbents' Other Non-Current Liabilities stood at $3.0 million in 2014, then plunged by 45.12% to $1.6 million in 2015, then climbed by 10.72% to $1.8 million in 2016, then plunged by 42.23% to $1.0 million in 2017.
• The last three Other Non-Current Liabilities figures came in at $1.0 million (Q2 2017), $1.7 million (Q1 2017), and $1.8 million (Q4 2016), per Business Quant data.